Hellen De Kloet, Biz Head-Western Europe & ANZ, Sun Pharma said the launch of ‘Gemcitabine InfuSMART‘ will start in the UK and the Netherlands because these are the first two countries in Europe where we have final approval.
"As part of its business strategy to build a meaningful and differentiating presence in global oncology therapy market, Sun Pharma today announced rollout of Gemcitabine InfuSMART in Europe. InfuSMART is a technology in which oncology products are developed in a ready-to-administer (RTA) bag," the company said in a BSE filing.